Phase 2 Thymic Carcinoma Clinical Trials

7 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–7 of 7 trials

Recruiting

Phase 2

HEARTS Trial for Thoracic Cancers

Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-III+2 more

University of Wisconsin, Madison60 enrolled1 locationNCT07132918

Recruiting

Phase 2

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

ThymomaThymic Carcinoma

Georgetown University18 enrolled4 locationsNCT06248515

Recruiting

Phase 2

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

ThymomaThymic Carcinoma

The First Affiliated Hospital with Nanjing Medical University20 enrolled1 locationNCT06838910

Recruiting

Phase 2

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Peritoneal MesotheliomaAnaplastic Thyroid CarcinomasCarcinoid Tumor+3 more

Hospices Civils de Lyon154 enrolled15 locationsNCT06790706

Recruiting

Phase 2

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Thymic Carcinoma

Dwight Owen30 enrolled3 locationsNCT03463460

Recruiting

Phase 2

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy

Jian Chen48 enrolled1 locationNCT06186726

Recruiting

Phase 2

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Untreated Advanced or Recurrent Thymic Carcinomas

National Cancer Center, Japan35 enrolled1 locationNCT05832827